Evropska unija -
norveščina -
EMA (European Medicines Agency)
sapropterin dipharma
dipharma arzneimittel gmbh - sapropterin dihydrochloride - phenylketonurias - andre alimentary tract and metabolism products, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.
Norveška -
norveščina -
Statens legemiddelverk
lacosamide medical valley 100 mg
medical valley invest ab - lakosamid - tablett, filmdrasjert - 100 mg
Norveška -
norveščina -
Statens legemiddelverk
lacosamide medical valley 50 mg
medical valley invest ab - lakosamid - tablett, filmdrasjert - 50 mg
Norveška -
norveščina -
Statens legemiddelverk
lacosamide medical valley 150 mg
medical valley invest ab - lakosamid - tablett, filmdrasjert - 150 mg
Norveška -
norveščina -
Statens legemiddelverk
lacosamide medical valley 200 mg
medical valley invest ab - lakosamid - tablett, filmdrasjert - 200 mg
Norveška -
norveščina -
Statens legemiddelverk
letrozol medical valley 2.5 mg
medical valley invest ab - letrozol - tablett, filmdrasjert - 2.5 mg
Norveška -
norveščina -
Statens legemiddelverk
lansoprazol medical valley 30 mg
medical valley invest ab - lansoprazol - enterokapsel, hard - 30 mg
Norveška -
norveščina -
Statens legemiddelverk
lansoprazol medical valley 15 mg
medical valley invest ab - lansoprazol - enterokapsel, hard - 15 mg
Norveška -
norveščina -
Statens legemiddelverk
anastrozol medical valley 1 mg
medical valley invest ab - anastrozol - tablett, filmdrasjert - 1 mg
Norveška -
norveščina -
Statens legemiddelverk
midazolam medical valley 2.5 mg
medical valley invest ab - midazolamhydroklorid - munnvann, oppløsning - 2.5 mg